Login  |   |  Search

The Patient Impact Initiative

The Patient Impact Initiative (PII) is the process through which Partnership for Cures generates, selects and manages Rediscovery Research™ projects to improve lives for patients.  We ask our research partners for their best ideas to test currently approved drugs, treatments and therapies for new patient populations; compile a portfolio of efficient medical research projects; and match these projects with funds to ensure their successful completion.


For Researchers - our current Request for Applications closed in March, 2012.  Projects will be reviewed for inclusion in our portfolio by the end of May. If you have a project you'd like to speak with us about, feel free to contact us

Projects which have been previously funded
Tangible ways in which we've helped

 

Our current portfolio contains 23 Rediscovery Research projects testing medical solutions for:

  • Cancer (breast, cervical, blood - CLL and CML)
  • Bronchiolitis Obliterans (lung)
  • C diff infection (gastrointestinal)
  • Cerebral Palsy 
  • Children’s blood diseases
  • Cystic Fibrosis
  • Epilepsy, IBD (gastrointestinal)
  • Muscular Dystrophy
  • Premature births
  • Sarcoidosis (autoimmune disease of the lungs and other organs)
  • Sickle Cell Anemia
  • SLE (Lupus)
  • Sjögren’s Syndrome
  • Type 1 Diabetes. 

We have 5 additional projects that might be included after resubmission in Schizophrenia, pulmonary hypertension,  Hydrocephalus, Brain Tumors, and Pulmonary Fibrosis. 

Another 20 Rediscovery Research projects are under consideration.

Eight projects are already funded or slated for funding:

  • metastatic breast cancer at U Chicago
  • children’s blood diseases at CHOP
  • myelodysplastic syndrome at Einstein Medical School and at Columbia
  • melanoma at Northwestern
  • pediatric brain cancer at Seattle Children's Hospital
  • two diabetes at University of Texas
  • a project in blood cancers partially funded

 
Partnership agreements are in place with Mayo Clinic, Cleveland Clinic, University of Chicago, Mass General, Harvard Medical School, Rush University Medical Center, UMass Medical Center, University of Southern CA, University of Texas Medical Branch, the Menninger Clinic, Seattle Children's Hospital, Saint Louis University, Sanford Burnham Institute, Ohio State University, University of Cincinnati, University of Washington, Los Angeles Basin Clinical and Translational Science Institute, Dalhousie University, Concordia University, Rutgers, CHOP/U Penn, Weill Cornell, and more to follow.